Indefinite Delivery Contract HHSN261201000043I
- This is an Indefinite Delivery Contract (IDC) awarded by the National Cancer Institute (NCI), a component of the U.S. Department of Health and Human Services, to Mayo Clinic, a renowned non-profit academic medical center. The contract is part of the NCI Cancer Genome Atlas Program Tissue Purchase IDIQ, with a ceiling value of $100,000.00 and a performance period through September 2014. Under this firm-fixed price delivery order contract, Mayo Clinic will provide tissue samples and data from...
- This is a firm fixed-price delivery order contract awarded by the National Cancer Institute (NCI) to Mayo Clinic, a renowned non-profit academic medical center. The contract, valued at $130,403.07, supports the NCI's Cancer Genome Atlas (TCGA) program by recovering tissue samples and data from various types of cancer. It is part of a larger $9.9 million NCI Cancer Genome Atlas Program Tissue Purchase indefinite delivery/indefinite quantity (IDIQ) contract, which allows the NCI to efficiently...
- This indefinite delivery contract was awarded by the National Cancer Institute (NCI), a component of the U.S. Department of Health and Human Services, to the Sloan-Kettering Institute for Cancer Research, a non-profit organization located in New York, NY. The contract, valued at $200,000, supports the NCI's Cancer Genome Atlas (TCGA) program, which aims to collect and analyze tissue samples and data from various cancer types. The initial $120,500 task order under this contract requires the...
- This indefinite delivery contract was awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS), to the non-profit organization Health Research, Inc. (HRI). The contract, valued at $765,306, supports the Cancer Genome Atlas (TCGA) program by providing tissue samples and data from various cancer types for genomic characterization. Under the contract, HRI's Roswell Park Division, doing business as...
- This indefinite delivery contract was awarded by the National Cancer Institute (NCI), a component of the U.S. Department of Health and Human Services, to Cedars-Sinai Medical Center, a nonprofit hospital and academic medical center located in Los Angeles. The $22,113 contract is for the recovery of tissue samples and data from various types of cancer to support the Cancer Genome Atlas (TCGA) program, which is part of the NCI's efforts related to the American Recovery and Reinvestment Act (ARRA)....
- This indefinite delivery contract was awarded by the National Cancer Institute (NCI), a civilian federal agency, to the Melanoma Institute Australia. The $192,500 firm fixed-price delivery order contract, part of the NCI's Cancer Genome Atlas (TCGA) program, involves the collection of tissue samples and data from various types of cancer. This work was funded under the American Recovery and Reinvestment Act (ARRA) and does not have a set-aside designation. The contract's period of performance...
- This indefinite delivery contract was awarded by the National Cancer Institute (NCI), a civilian agency within the U.S. Department of Health and Human Services, to the Sloan-Kettering Institute for Cancer Research, a non-profit organization. The contract, valued at $236,000.00, is part of the NCI Cancer Genome Atlas (TCGA) Program and aims to procure tissue samples and data from various cancer types for the TCGA's comprehensive genomic characterization efforts. The contract was awarded in August...
- This indefinite delivery contract was awarded by the National Cancer Institute (NCI), a component of the Department of Health and Human Services (HHS), to the Sloan-Kettering Institute for Cancer Research, a non-profit organization. The $178,230 firm fixed-price delivery order is for the recovery and delivery of tissue samples and data from various types of cancer for the Cancer Genome Atlas (TCGA) program, which is part of the agency's efforts to characterize the genomic changes in cancer....
- The National Cancer Institute (NCI) awarded an indefinite delivery/indefinite quantity (IDIQ) contract to The Johns Hopkins University to support the Cancer Genome Atlas (TCGA) program, which was funded under the American Recovery and Reinvestment Act (ARRA). The $159,600 multiple-award IDIQ contract, with a period of performance through March 2015, allows NCI to issue task orders for the acquisition of tissue samples and data from various cancer types for the TCGA program. A $129,675 firm...
- This indefinite delivery contract (IDC) was awarded by the National Cancer Institute (NCI), a civilian agency, to The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. (HJF), a non-profit organization. The $301,548 contract, with no set-aside designation, is for the recovery and procurement of tissue samples and data from various types of cancer to support the Cancer Genome Atlas (TCGA) program, which is funded by the American Recovery and Reinvestment Act (ARRA). The...
- HHSN261201000043IIndefinite Delivery Contract
- 1Federal Contract Awards
This indefinite delivery contract (HHSN261201000043I) was awarded by the National Cancer Institute (NCI) to Mayo Clinic, a renowned non-profit academic medical center, to support the Cancer Genome Atlas (TCGA) program under the American Recovery and Reinvestment Act (ARRA). The contract has a fixed ceiling value of $6,663.53 and a period of performance from June 21, 2010 to August 28, 2013, with no set-aside designation. Under this delivery order, Mayo Clinic is tasked with recovering tissue samples and data from various cancer types for the TCGA program. Mayo Clinic has extensive expertise in cancer research, drug development, and clinical services, and has been awarded multiple federal contracts and grants by agencies like the NCI and the Defense Health Agency. This contract is a task order under the NCI's Cancer Genome Atlas Program Tissue Purchase indefinite delivery/indefinite quantity (IDIQ) contract, which allows the NCI to efficiently access Mayo Clinic's capabilities in supporting the advancement of cancer therapies from laboratory to clinical application.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| 5 | Other Administrative Action | $0 | 5/23/13 | |
| 4 | Other Administrative Action | $0 | 4/12/13 | |
| 3 | Other Administrative Action | $0 | 11/19/12 | |
| 2 | Other Administrative Action | $0 | 10/27/11 | |
| 1 | Supplemental Agreement for work within scope | $0 | 9/14/10 |
Name | Description | Awardee | Potential Value | AwardDate | CompletionDate | Updated At |
|---|---|---|---|---|---|---|
Delivery Order HHSN261201000043I-HHSN26100001 | Mayo Clinic | $6.7k | 6/21/10 | 8/28/13 | 8/28/13 |
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
RECOVERY- Tissue Purchase Order Contract Acquisition for NCI's The Cancer Genome Atlas Program | RFQ-NCI-10008-AS | Department of Health and Human Services National Institutes of Health | Award Notice 1/1 | 12/4/09, 11:10 AM |